What is the recommended dosing schedule and available tube sizes for Taclonex (calcipotriene 0.005% w/w and betamethasone dipropionate 0.064% w/w) for scalp psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Taclonex Dosing and Supply for Scalp Psoriasis

For scalp psoriasis, apply Taclonex Topical Suspension (calcipotriene 0.005%/betamethasone dipropionate 0.064%) once daily for 4-12 weeks, with a maximum weekly dose of 100 grams for adults (18+ years) or 60 grams for adolescents (12-17 years), and the product is supplied in 60-gram bottles or 120-gram packages (two 60-gram bottles). 1

Dosing Schedule

Application Frequency and Duration

  • Once daily application to affected scalp areas 1
  • Treatment duration: 4-12 weeks as recommended by AAD-NPF guidelines 2
  • Discontinue when control is achieved unless directed otherwise by your healthcare provider 1

Maximum Weekly Doses

  • Adults (≥18 years): 100 grams per week maximum 1
  • Adolescents (12-17 years): 60 grams per week maximum 1

These dose limits are critical to avoid systemic absorption and potential adverse effects including hypercalcemia and HPA axis suppression 1.

How Supplied

Taclonex Topical Suspension is available in:

  • 60-gram bottle (NDC 50222-501-06) 1
  • 120-gram package containing two 60-gram bottles (NDC 50222-501-66) 1

Storage Requirements

  • Store at room temperature 68°F-77°F (20°C-25°C) 1
  • Do not refrigerate 1
  • Keep bottle in carton when not in use 1
  • Discard unused product 6 months after opening 1
  • Shake bottle before each use 1

Application Technique for Scalp

The FDA label provides specific instructions 1:

  1. No need to wash hair before application
  2. Shake the bottle before use
  3. Part hair to locate affected areas
  4. Squeeze a drop onto fingertip
  5. Apply directly to affected scalp areas and gently rub in
  6. Replace cap after application
  7. Wash hands after applying
  8. Do not wash hair immediately after application

Evidence Supporting This Recommendation

The 2021 AAD-NPF guidelines provide Grade A evidence (strongest recommendation) for using calcipotriene plus betamethasone dipropionate gel/suspension for 4-12 weeks in scalp psoriasis 2. This recommendation is based on multiple RCTs showing 67-70% of patients achieved clear or almost clear scalp psoriasis at 8 weeks 2. The combination product demonstrated superior efficacy compared to either agent alone 2.

Important Clinical Caveats

Timing Restrictions

  • Avoid application within 12 hours before or after chemical hair treatments (perms, relaxers, dyes) 1
  • Apply after phototherapy sessions if combining treatments, as UV radiation can inactivate calcipotriene 2

Areas to Avoid

  • Do not use on face, underarms, groin, or eyes 1
  • If accidental contact occurs, wash area immediately 1

Safety Monitoring

For adolescents with extensive scalp involvement (≥20% of scalp), one study reported mild adrenal suppression in 1 of 31 patients at week 4, which resolved after discontinuation 3. While generally well-tolerated, monitor for signs of HPA axis suppression with extensive use 1.

Long-term Use

A 52-week study demonstrated that 69-74% of patients maintained clear or almost clear status with once or twice daily application, with no serious adverse events including striae or HPA axis suppression 2. However, the standard recommendation remains 4-12 weeks for acute treatment 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.